दवाओं की अंतःक्रिया
Certolizumab pegol + Ciltacabtagene autoleucel
गंभीरता: गंभीर
Certolizumab pegol and Ciltacabtagene autoleucel: major interaction.
अंतिम अपडेट
केवल स्वास्थ्य पेशेवरों के लिए — मात्र संदर्भ हेतु। यह पृष्ठ संक्षिप्त सारांश है, चिकित्सकीय सलाह नहीं है और आधिकारिक लेबल या नैदानिक निर्णय का विकल्प नहीं है। दवा लिखने या देने से पहले हमेशा जाँच करें।
इस पृष्ठ की नैदानिक सामग्री केवल अंग्रेज़ी में उपलब्ध है।
सारांश
Certolizumab pegol blocks TNF and causes immunosuppression, while ciltacabtagene autoleucel is given after lymphodepleting chemotherapy and causes prolonged cytopenias and hypogammaglobulinemia. Together they may raise the risk of serious infection. TNF inhibition may also interfere with CAR-T expansion and cytokine biology.
इस इंटरैक्शन का सरल भाषा में अर्थ
Certolizumab pegol and Ciltacabtagene autoleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Certolizumab pegol belongs to Musculoskeletal; Ciltacabtagene autoleucel belongs to Miscellaneous.
ऐसा क्यों होता है
Additive immunosuppression from TNF blockade and CAR-T related lymphodepletion and cytopenias.
क्या करें
Avoid starting certolizumab pegol around CAR-T infusion unless clearly needed, and consider an alternative. If it cannot be avoided, monitor closely for infection and cytopenias.
फार्मासिस्ट से क्या पूछें
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ सदस्यों के लिए
पूरा पेज खोलें
Certolizumab pegol और Ciltacabtagene autoleucel की पूरी प्रबंधन सलाह, अतिरिक्त नोट्स, साक्ष्य का विवरण और पूरे पर्चे का इंटरैक्शन चेकर खोलने के लिए खाता बनाएँ और Pro+ ट्रायल शुरू करें।
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
वेब पर Pro+ को 14 दिन मुफ़्त आज़माएँ। कार्ड की ज़रूरत नहीं।
Certolizumab pegol के अन्य इंटरैक्शन
- Adenovirus types 4 and 7 live + Certolizumab pegol निषिद्ध
- Bcg intravesical live + Certolizumab pegol निषिद्ध
- Bcg vaccine live + Certolizumab pegol निषिद्ध
- Certolizumab pegol + Influenza virus vaccine quadrivalent intranasal निषिद्ध
- Certolizumab pegol + Measles mumps and rubella vaccine निषिद्ध
- Certolizumab pegol + Measles mumps and rubella vaccine live निषिद्ध
Ciltacabtagene autoleucel के अन्य इंटरैक्शन
अक्सर पूछे जाने वाले प्रश्न
Can I take Certolizumab pegol with Ciltacabtagene autoleucel?
MediHelp rates the interaction as major. Certolizumab pegol and Ciltacabtagene autoleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Certolizumab pegol blocks TNF and causes immunosuppression, while ciltacabtagene autoleucel is given after lymphodepleting chemotherapy and causes prolonged cytopenias and hypogammaglobulinemia. Together they may raise the risk of serious infection. TNF inhibition may also interfere with CAR-T expansion and cytokine biology.
How serious is the interaction between Certolizumab pegol and Ciltacabtagene autoleucel?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid starting certolizumab pegol around CAR-T infusion unless clearly needed, and consider an alternative. If it cannot be avoided, monitor closely for infection and cytopenias.
What other medicines interact with Certolizumab pegol?
MediHelp also lists interactions of Certolizumab pegol with, for example, Adenovirus types 4 and 7 live, Bcg intravesical live, Bcg vaccine live. The full list is on the Certolizumab pegol page.
MediHelp ऐप में पूर्ण मोनोग्राफ़, खुराक और इंटरैक्शन चेकर
MediHelp ऐप में पूरा संदर्भ खोलें, कई दवाओं की अंतःक्रियाएँ जाँचें और खुराक टूल इस्तेमाल करें।
